NYSEAMERICAN:IBIO

iBio Insider Trades

$0.76

-0.02 (-2.56 %)

(As of 10/27/2021 12:00 AM ET)

Add

Compare

Today's Range: $0.76
▼
$0.79
50-Day Range: N/A
52-Week Range: $0.76
▼
$2.83

Volume: 2.67 million shs
Average Volume: 8.85 million shs
Market Capitalization: $165.82 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: -6.24

iBio (NYSEAMERICAN:IBIO) Insider Buying and Selling Activity

1.00% of iBio's shares are owned by company executives, directors and other insiders.

Insider Buying and Selling by Quarter

iBio (NYSEAMERICAN IBIO) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/11/2020	Eastern Capital Ltd	Major Shareholder	Sell	24,484,904	$3.27	$80,065,636.08
8/6/2020	Eastern Capital Ltd	Major Shareholder	Sell	2,768,137	$4.18	$11,570,812.66	36,782,734
8/4/2020	Eastern Capital Ltd	Major Shareholder	Sell	600,000	$4.39	$2,634,000.00	36,782,734
6/4/2020	Robert L. Erwin	President	Sell	28,268	$1.71	$48,338.28
6/2/2020	Robert L. Erwin	President	Sell	96,124	$1.62	$155,720.88
5/27/2020	James P. Mullaney	CFO	Sell	11,250	$1.61	$18,112.50
7/12/2018	Eastern Capital Ltd	Major Shareholder	Buy	2,200,000	$0.90	$1,980,000.00	8,457,734
6/26/2018	Eastern Capital Ltd	Major Shareholder	Buy	1,683,334	$0.90	$1,515,000.60	6,257,734
11/30/2017	Eastern Capital Ltd	Major Shareholder	Buy	12,000,000	$0.20	$2,400,000.00	45,744,000
4/7/2016	Eastern Capital Ltd	Major Shareholder	Buy	6,500,000	$0.62	$4,030,000.00	33,744,000
1/25/2016	Eastern Capital Ltd	major shareholder	Buy	3,500,000	$0.62	$2,170,000.00	27,244,000
9/17/2014	Carl Desantis	Major Shareholder	Sell	138,710	$0.67	$92,935.70
2/3/2014	Carl Desantis	Major Shareholder	Sell	28,828	$0.55	$15,855.40
1/31/2014	Carl Desantis	Major Shareholder	Sell	74,049	$0.56	$41,467.44
1/29/2014	Carl Desantis	Major Shareholder	Sell	128,708	$0.58	$74,650.64
8/13/2013	Carl Desantis	Major Shareholder	Sell	37,689	$0.50	$18,844.50
8/8/2013	Carl Desantis	Major Shareholder	Sell	324,395	$0.54	$175,173.30
8/6/2013	Carl Desantis	Major Shareholder	Sell	53,065	$0.50	$26,532.50
8/2/2013	Carl Desantis	Major Shareholder	Sell	99,945	$0.50	$49,972.50
7/30/2013	Carl Desantis	Major Shareholder	Sell	34,605	$0.51	$17,648.55
7/26/2013	Carl Desantis	Major Shareholder	Sell	27,255	$0.50	$13,627.50
7/23/2013	Carl Desantis	Major Shareholder	Sell	39,465	$0.51	$20,127.15
7/19/2013	Carl Desantis	Major Shareholder	Buy	1,732,679	$0.52	$900,993.08

(Data available from 1/1/2013 forward)

iBio (NYSEAMERICAN:IBIO) Insider Trade Frequently Asked Questions

Who is on iBio's Insider Roster?: The list of insiders at iBio includes Eastern Capital Ltd, James P. Mullaney, and Robert L. Erwin.Learn more on IBIO's insiders
What percentage of iBio stock is owned by insiders?: 1.00% of iBio stock is owned by insiders. Learn more on IBIO's insider holdings

Which iBio insiders have been selling company stock?: The following insiders have sold iBio stock in the last 24 months: Eastern Capital Ltd ($94,270,448.74), James P. Mullaney ($18,112.50), and Robert L. Erwin ($204,059.16).
How much insider selling is happening at iBio?: Insiders have sold a total of 27,988,683 iBio shares in the last 24 months for a total of $94,492,620.40 sold.

This page was last updated on 10/28/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources